【罂粟摘要】艾氯胺酮对老年男性输尿管镜成功插入异丙酚ED50的影响:一项随机对照试验

文摘   2024-10-14 07:03   贵州  

关注罂粟花,共同学习麻醉学最新文献!



艾氯胺酮对老年男性输尿管镜成功插入异丙酚ED50的影响:一项随机对照试验





贵州医科大学  麻醉与心脏电生理课题组

翻译:王波  编辑:王婷婷  审校:曹莹

背景:异丙酚在输尿管镜手术镇静麻醉(PSA)中是一种有效的常规麻醉剂。然而,在异丙酚为基础的PSA中,呼吸抑制和无意识的身体活动经常发生,尤其是在老年患者中。艾氯胺酮具有镇静和镇痛作用,但无心肺抑制风险。本研究旨在探讨艾氯胺酮是否能降低老年男性输尿管镜置入成功的异丙酚中位有效剂量(ED50)。

材料与方法:将49例择期硬输尿管镜老年男性患者随机分为SK组(0.25 mg/kg艾氯胺酮+异丙酚)和SF组(0.1µg/kg舒芬太尼+异丙酚)。两组患者在静脉给予舒芬太尼或艾氯胺酮后,均给予异丙酚,初始剂量为1.5 mg/kg。异丙酚的有效剂量采用改良的Dixon法评估,然后根据患者既往反应调整为0.1 mg/kg。患者对输尿管镜插入的反应分为“活动”和“不活动”。主要终点是异丙酚与艾氯胺酮或舒芬太尼输尿管镜成功插入的ED50。次要指标包括诱导时间,不良事件如血流动力学改变、低氧血症和身体运动也被测量。

结果:49例患者入组并完成研究。SK组输尿管镜成功插入丙泊酚的ED50为1.356±0.11 mg/kg,低于SF组的1.442±0.08 mg/kg (P = 0.003)。SK组诱导时间明显短于SF组(P = 0.001)。SK组血流动力学指标较SF组稳定。两组不良事件发生率无显著差异。



结论:异丙酚联合艾氯胺酮用于老年男性输尿管镜插入患者的ED50为1.356±0.11 mg/kg,与舒芬太尼相比显著降低。

Effect of esketamine on the ED50 of propofol  for successful insertion of ureteroscope  in elderly male patients: a randomized  controlled trial


Background Propofol is effective and used as a kind of routine anesthetics in procedure sedative anesthesia (PSA) for ureteroscopy. However, respiratory depression and unconscious physical activity always occur during propofol-based PSA, especially in elderly patients. Esketamine has sedative and analgesic effects but without risk of cardiorespiratory depression. The purpose of this study is to investigate whether esketamine can reduce the propofol median effective dose (ED50) for successful ureteroscope insertion in elderly male patients.

Materials and methods 49 elderly male patients undergoing elective rigid ureteroscopy were randomly divided into two groups: SK Group (0.25 mg/kg esketamine+propofol) and SF Group (0.1 µg/kg sufentanil+propofol).

Patients in both two groups received propofol with initial bolus dose of 1.5 mg/kg after sufentanil or esketamine was administered intravenously. The effective dose of propofol was assessed by a modified Dixon’s up-and-down method and then was adjusted with 0.1 mg/kg according to the previous patient response. Patients’ response to ureteroscope insertion was classified as “movement” or “no movement” . The primary outcome was the ED50 of propofol for successful ureteroscope insertion with esketamine or sufentanil. The secondary outcomes were the induction time, adverse events such as hemodynamic changes, hypoxemia and body movement were also measured.

Result 49 patients were enrolled and completed this study. The ED50 of propofol for successful ureteroscope insertion in SK Group was 1.356 ± 0.11 mg/kg, which was decreased compared with that in SF Group, 1.442 ± 0.08 mg/kg (P = 0.003). The induction time in SK Group was significantly shorter than in SF Group (P = 0.001). In SK Group, more stable hemodynamic variables were observed than in SF Group. The incidence of AEs between the two groups was not significantly different.

Conclusion The ED50 of propofol with esketamine administration for ureteroscope insertion in elderly male patients is 1.356 ± 0.11 mg/kg, significantly decreased in comparsion with sufentanil.


原文链接:Effect of esketamine on the ED50 of propofol for successful insertion of ureteroscope in elderly male patients a randomized controlled trial.pdf 

END

罂粟花
罂粟花,临床麻醉医生的文献阅读平台!
 最新文章